Spis treści:
4. PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
| KOMISJA NADZORU FINANSOWEGO | ||||||||||||
| Raport bieżący nr | 6 | / | 2022 | |||||||||
| Data sporządzenia: | 2022-07-07 | |||||||||||
| Skrócona nazwa emitenta | ||||||||||||
| MILESTONE MEDICAL | ||||||||||||
| Temat | ||||||||||||
| Commencing Sales of CompuFlo® Epidural disposables to a leading medical center in Southern California | ||||||||||||
| Podstawa prawna | ||||||||||||
| Art. 17 ust. 1 MAR - informacje poufne. | ||||||||||||
| Treść raportu: | ||||||||||||
| The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company", “the Issuer"), today announced that following a successful trial and evaluation, it has commenced sales of its CompuFlo® Epidural disposables to a leading medical center in Southern California, which has been designated as one of the America’s Best Maternity Care Hospitals 2022 by Newsweek. This medical center also belongs to one of the nation’s largest not-for-profit healthcare systems serving over 10 million members, with more than 100,000 babies delivered each year across multiple states. The name of the hospital cannot be disclosed for confidentiality reasons. The Board of Directors of the Company is honored to have been approved as a vendor to commence sales of CompuFlo Epidural disposables within a leading medical center in Southern California. The addition of this hospital illustrates the continued traction in the labor and delivery market across the country, and further validates the favorable response to our technology by leading anesthesiologists. |
||||||||||||
| MESSAGE (ENGLISH VERSION) | |||
INFORMACJE O PODMIOCIE >>>
| PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
| 2022-07-07 | Keisha Harcum | Controller | Keisha Harcum | ||
Źródło:Komunikaty spółek (ESPI)
